Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bronchodilator response in elderly patients].

S A Quadrelli1, A J Roncoroni, A Sacerdotti

  • 1Instituto de Investigaciones Médicas Alfredo Lanari, Facultad de Medicina, Universidad de Buenos Aires.

Medicina
|July 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies.

Lupus·2009
Same author

[Argentine consensus on sleep-related breathing disorders].

Medicina·2002
Same author

Features of asthma in the elderly.

The Journal of asthma : official journal of the Association for the Care of Asthma·2001
Same author

[Twelve rules for a good clinical history in the era of managed medicine].

Medicina·2001
Same author

Nocturnal ventilation in neuromuscular diseases.

The European respiratory journal·2000
Same author

[Beta-agonists in the treatment of bronchial asthma].

Archivos de bronconeumologia·2000
Same journal

Detection of VIM-3 in oral squamous cell carcinomas: methodological limitations.

Medicina·2026
Same journal

The importance of specific antibodies in VIM-3 research: addressing a key methodological flaw.

Medicina·2026
Same journal

[From the right to be cared for to the duty to care: Legal bases for the implementation of palliative care in Argentina].

Medicina·2026
Same journal

[Surrogacy].

Medicina·2026
Same journal

[The misunderstandings in interpreting the "diagnostic superiority of Artificial Intelligence" and the explainable Artificial Intelligence].

Medicina·2026
Same journal

[Artificial intelligence in medicine: between algorithmic opacity and clinical responsibility].

Medicina·2026
See all related articles

Bronchodilator response in elderly asthma patients is preserved, regardless of age. However, expressing reversibility as a percentage of initial lung function can be misleading due to baseline airway obstruction levels.

Area of Science:

  • Pulmonology
  • Geriatric Medicine
  • Respiratory Medicine

Context:

  • Elderly asthma patients often exhibit more severe disease.
  • Bronchodilator response and reversibility metrics in this population are not fully understood.
  • Existing methods for expressing bronchodilator reversibility lack consensus.

Purpose:

  • To evaluate bronchodilator response in elderly asthmatics.
  • To compare response across different levels of airway obstruction.
  • To assess various indices for expressing reversibility.

Summary:

  • Bronchodilator response, measured by absolute change, percentage of predicted, or percentage of maximal change, did not differ between elderly (>=65 years) and younger (<40 years) asthma patients.
  • Reversibility expressed as a percentage of initial lung function (delta%initial) was lower in younger patients, suggesting age-related differences.

Related Experiment Videos

  • Covariance analysis, controlling for baseline FEV1, indicated no significant age-related differences in bronchodilator response.
  • Delta%initial showed a weak correlation with age but a strong dependence on baseline FEV1, highlighting its sensitivity to initial airway obstruction.

    • Impact:

    • Bronchodilator reversibility in elderly asthmatics is generally preserved.
    • The choice of reversibility index significantly impacts study outcomes, particularly delta%initial.
    • Findings emphasize the need for standardized methods in assessing bronchodilator response in diverse asthma populations.